developing a broad pipeline of therapies to extend human healthspan and lifespan
We’re an interdisciplinary team of computational biologists, experimental scientists, and seasoned drug hunters. We share the vision that targeting aging directly, rather than targeting individual age-related diseases one at a time, will have a dramatic positive impact on human health.
The BIOAGE discovery platform leverages recent technological advances to create a deep omics map of human aging. We generate this map by applying novel machine learning and bioinformatics approaches to proprietary human cohort data to reveal the molecular drivers of age-related pathology. Our pipeline of therapies targeting these key pathways will address the significant unmet medical needs of an aging population.
At BIOAGE, we are mapping human aging from the ground up. We have forged partnerships with unique biobanks containing healthy human samples collected over decades that are paired with extensive follow-up records that include detailed future healthspan, lifespan, and disease outcomes. We are building deep molecular profiles of these samples, incorporating proteomics, metabolomics, and transcriptomics to identify the best drug targets for healthy aging.
Visit website: https://bioagelabs.com/
BIOAGE is also referenced in the following:
Online event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen chaired by Morten Scheibye-Knudsen, Daniela Bakula and Alex Zhavoronkov, and with many speakers.
BBC Click meets biohackers and companies who believe it will be possible to live on to well beyond 100
People at BIOAGE
CEO at BIOAGE.
Chief Medical Officer at Bioage Labs and Pharma and biotech Consultant at Rubin Pharma.
Bioage licenses new drugs to treat ageing and age-related diseases
Lifespan.io (LEAF) - 28-Apr-2021
Raised $90M in series C funding - off to a great start initiating three clinical trialsRead more...
BioAge's anti-ageing drug to treat Covid-19 enters phase 2 trial
Longevity Technology - 22-Mar-2021
Reverses immune ageing and can prevent death from coronavirus infection in the elderlyRead more...
Bioage's lead therapies moved closer to the clinic
Longevity Technology - 03-Dec-2020
Lead therapies of BioAge to treat age related diseases enter phase 2 trialsRead more...
Why people should take up a career in the aging research industry
Lifespan.io (LEAF) - 26-Feb-2020
I think Victor is right, anti-aging is going to be the next big thingRead more...